- Home
- KROS vs FMNB Comparison
KROS vs FMNB Comparison
Compare KROS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- FMNB
- Stock Information
- Founded
- KROS 2015
- FMNB 1887
- Country
- KROS United States
- FMNB United States
- Employees
- KROS N/A
- FMNB N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- FMNB Major Banks
- Sector
- KROS Health Care
- FMNB Finance
- Exchange
- KROS Nasdaq
- FMNB Nasdaq
- Market Cap
- KROS 460.6M
- FMNB 574.7M
- IPO Year
- KROS 2020
- FMNB N/A
- Fundamental
- Price
- KROS $11.00
- FMNB $13.91
- Analyst Decision
- KROS Buy
- FMNB Hold
- Analyst Count
- KROS 11
- FMNB 4
- Target Price
- KROS $45.33
- FMNB $15.75
- AVG Volume (30 Days)
- KROS 2.1M
- FMNB 70.5K
- Earning Date
- KROS 02-26-2025
- FMNB 01-29-2025
- Dividend Yield
- KROS N/A
- FMNB 4.89%
- EPS Growth
- KROS N/A
- FMNB N/A
- EPS
- KROS N/A
- FMNB 1.22
- Revenue
- KROS $651,000.00
- FMNB $162,118,000.00
- Revenue This Year
- KROS $303.27
- FMNB N/A
- Revenue Next Year
- KROS N/A
- FMNB $5.96
- P/E Ratio
- KROS N/A
- FMNB $11.25
- Revenue Growth
- KROS 8037.50
- FMNB N/A
- 52 Week Low
- KROS $9.78
- FMNB $11.55
- 52 Week High
- KROS $73.00
- FMNB $16.32
- Technical
- Relative Strength Index (RSI)
- KROS 24.79
- FMNB 47.33
- Support Level
- KROS $11.04
- FMNB $13.61
- Resistance Level
- KROS $11.99
- FMNB $14.30
- Average True Range (ATR)
- KROS 0.60
- FMNB 0.34
- MACD
- KROS 1.20
- FMNB 0.11
- Stochastic Oscillator
- KROS 43.99
- FMNB 58.09
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About FMNB Farmers National Banc Corp.
Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of company's revenue is derived from the bank segment.